Kraig Biocraft Laboratories develops new breakthrough Spider Silk DNA Synthesis Protocols accelerating time to market for new products

Kraig Labs’ R&D team raises the bar in transgenic research

ANN ARBOR, Mich., – May 23, 2018 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announces today that its R&D team has achieved a major breakthrough in the construction of DNA encoding for spider silk proteins. 

With this new capability the Company believes that it should be able to reduce the customization timeframe, for new spider silk technologies, by several months.

The new protocols were developed after Kraig Labs reached out to leading DNA synthesis facilities, which all stated that construction of the desired sequences would be practically impossible, due to the unique structure of spider silk proteins.  Refusing to accept that answer, Kraig’s research team then took on the task directly. 

Using a combination of distinct approaches, Kraig Labs successfully synthesized the highly complex set of spider silk protein construct designs.  This new approach should accelerate the pace of its research and production rollout efforts, as well as reduce costs to develop new transgenics for new potential markets and applications. 

The newly designed protein constructs are currently being prepared for incorporation into the Company’s spider silk platform technology.  Due to their construction, these new designs may have the potential to produce new silk fibers with even greater strength and flexibility than the Company’s current generation of recombinant spider silk. 

“Today’s announcement is another in a long history of Kraig Labs proving the impossible, possible,” said Jon Rice, COO.  “From our first transgenic silkworms, to the creation of Monster Silk and then Dragon Silk, to obtaining approvals for international expansion, the Company has proven, time and time again, that we have the tenacity to reimagine what is possible. These new constructs and the ability to rapidly adapt them could open new and wider applications in military and high performance technical textile markets.  Today we celebrate yet another example of how the Company is changing the rules in biotech development.”

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to   

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (, a reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495


This entry was posted on by .